These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 29757350)

  • 41. Long-term Treatment With Proton Pump Inhibitors Is Effective in Children With Eosinophilic Esophagitis.
    Gutiérrez-Junquera C; Fernández-Fernández S; Cilleruelo ML; Rayo A; Echeverría L; Borrell B; Román E
    J Pediatr Gastroenterol Nutr; 2018 Aug; 67(2):210-216. PubMed ID: 29509636
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Esophageal eosinophilia in children: A 6-year single-center experience.
    Çakır M; Sağ E; Mungan S; Akbulut UE; Orhan F
    Turk J Pediatr; 2017; 59(4):369-378. PubMed ID: 29624216
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effectiveness of PPI treatment and guideline adherence in 236 patients with eosinophilic oesophagitis-Results from the population-based DanEoE cohort shows a low complication rate.
    Frandsen LT; Westmark S; Melgaard D; Krarup AL
    United European Gastroenterol J; 2021 Oct; 9(8):910-918. PubMed ID: 34477326
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proton pump inhibitor-responsive esophageal eosinophilia: still a valid diagnosis?
    Molina-Infante J; Gonzalez-Cordero PL; Lucendo AJ
    Curr Opin Gastroenterol; 2017 Jul; 33(4):285-292. PubMed ID: 28445189
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Longitudinal Evaluation of Noninvasive Biomarkers for Eosinophilic Esophagitis.
    Min SB; Nylund CM; Baker TP; Ally M; Reinhardt B; Chen YJ; Nazareno L; Moawad FJ
    J Clin Gastroenterol; 2017 Feb; 51(2):127-135. PubMed ID: 27479142
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Determinant factors for first-line treatment choice and effectiveness in pediatric eosinophilic esophagitis: an analysis of the EUREOS EoE CONNECT registry.
    Navarro P; Feo-Ortega S; Casabona-Francés S; Gutiérrez-Junquera C; Savarino EV; Amorena E; Fernández-Fernández S; Pérez-Martínez I; Oliva S; Barrio J; Masiques-Mas ML; Guardiola-Arévalo A; Guagnozzi D; Racca F; Betoré E; Votto M; Rodríguez-Sánchez A; Barrio ML; Blas-Jhon L; Sánchez-Vegazo CT; García-Morales N; Krarup AL; Dainese R; Martín-Dominguez V; García-Díaz A; Maniero D; Santander C; Arias Á; Laserna-Mendieta EJ; Lucendo AJ
    Eur J Pediatr; 2024 Aug; 183(8):3567-3578. PubMed ID: 38819501
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-Term Loss of Response in Proton Pump Inhibitor-Responsive Esophageal Eosinophilia Is Uncommon and Influenced by CYP2C19 Genotype and Rhinoconjunctivitis.
    Molina-Infante J; Rodriguez-Sanchez J; Martinek J; van Rhijn BD; Krajciova J; Rivas MD; Barrio J; Moawad FJ; Martinez-Alcalá C; Bredenoord AJ; Zamorano J; Dellon ES
    Am J Gastroenterol; 2015 Nov; 110(11):1567-75. PubMed ID: 26416193
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Age-based differences in the diagnosis and management of esophageal eosinophilia.
    Rassbach W; Rubenstein JH; Elkins M; DeMatos V; Greenson JK; Greenhawt M
    J Allergy Clin Immunol Pract; 2015; 3(1):81-87.e1. PubMed ID: 25577623
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An improved guideline adherence and PPI efficacy has been accompanied by a decrease in diagnostic delay, and strictures before diagnosis of eosinophilic esophagitis in the North Denmark Region - a retrospective registry study of the DanEoE cohorts.
    Melgaard D; Hansen AB; Pedersen C; Sandholm E; Hansen TB; Frandsen LT; Krarup AL
    Clin Res Hepatol Gastroenterol; 2023 Aug; 47(7):102159. PubMed ID: 37307949
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Eosinophilic esophagitis: Update in diagnosis and management. Position paper by the Italian Society of Gastroenterology and Gastrointestinal Endoscopy (SIGE).
    de Bortoli N; Penagini R; Savarino E; Marchi S
    Dig Liver Dis; 2017 Mar; 49(3):254-260. PubMed ID: 27979389
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of eosinophilic esophagitis is often discordant with guidelines and not patient-centered: results of a survey of gastroenterologists.
    Chang JW; Saini SD; Mellinger JL; Chen JW; Zikmund-Fisher BJ; Rubenstein JH
    Dis Esophagus; 2019 Jun; 32(6):. PubMed ID: 30715230
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The outcome of patients with oesophageal eosinophilic infiltration after an eight-week trial of a proton pump inhibitor.
    Vazquez-Elizondo G; Ngamruengphong S; Khrisna M; Devault KR; Talley NJ; Achem SR
    Aliment Pharmacol Ther; 2013 Nov; 38(10):1312-9. PubMed ID: 24117619
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proton Pump Inhibitor Therapy in Eosinophilic Esophagitis: Predictors of Nonresponse.
    Alexander R; Alexander JA; Akambase J; Harmsen WS; Geno D; Tholen C; Katzka DA; Ravi K
    Dig Dis Sci; 2021 Sep; 66(9):3096-3104. PubMed ID: 32995996
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proton pump inhibitor responsive esophageal eosinophilia, a distinct disease entity?
    Munday W; Zhang X
    World J Gastroenterol; 2014 Aug; 20(30):10419-24. PubMed ID: 25132757
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Distinguishing GERD from eosinophilic oesophagitis: concepts and controversies.
    Kia L; Hirano I
    Nat Rev Gastroenterol Hepatol; 2015 Jul; 12(7):379-386. PubMed ID: 25986303
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Eosinophilic esophagitis: is it also a surgical disease?
    Rea F; Caldaro T; Tambucci R; Romeo EF; Caloisi C; Torroni F; di Abriola GF; Foschia F; Francalanci P; Dall'Oglio L; De Angelis P
    J Pediatr Surg; 2013 Feb; 48(2):304-8. PubMed ID: 23414856
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proton pump inhibitor therapy reverses endoscopic features of fibrosis in eosinophilic esophagitis.
    Navarro P; Laserna-Mendieta EJ; Guagnozzi D; Casabona S; Perelló A; Savarino E; de la Riva S; Olalla JM; Ghisa M; Serrano-Moya N; Alcolea-Valero C; Ortega-Rabbione G; Majano P; Santander C; Arias Á; Lucendo AJ;
    Dig Liver Dis; 2021 Nov; 53(11):1479-1485. PubMed ID: 34120859
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interactions between gastro-oesophageal reflux disease and eosinophilic oesophagitis.
    Molina-Infante J; van Rhijn BD
    Best Pract Res Clin Gastroenterol; 2015 Oct; 29(5):749-758. PubMed ID: 26552774
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Case report of proton pump inhibitor responsive esophageal eosinophilia: why 2 months of proton pump inhibitors is required.
    Lipka S; Muhammad A; Champeaux A; Richter JE
    Dis Esophagus; 2016 Aug; 29(6):700-3. PubMed ID: 24842729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.